Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

2(25%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_2

63%

Ph phase_3

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 2Efficacy & side effects

5(62.5%)

Phase 3Large-scale testing

3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Other(2)

Detailed Status

Completed4

unknown2

Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 25 (62.5%)

Phase 33 (37.5%)

Trials by Status

unknown225%

completed450%

active_not_recruiting225%

Recent Activity

2 active trials

Showing 5 of 8

active_not_recruitingphase_3

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

NCT00002462

active_not_recruitingphase_3

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

NCT00379041

completedphase_2

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

NCT00574496

completedphase_2

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

NCT00002715

unknownphase_3

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

NCT00041210

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT00002462Phase 3

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Active Not Recruiting

NCT00379041Phase 3

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Active Not Recruiting

NCT00574496Phase 2

Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma

Completed

NCT00002715Phase 2

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma

Completed

NCT00041210Phase 3

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

Unknown

NCT00003262Phase 2

Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

Unknown

NCT00002714Phase 2

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

Completed

NCT00002463Phase 2

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors

Completed

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8